Multinationals expressing discontent over Korea’s drug price reform

The Korean government’s Drug Price Reform plan would limit Korean patients’ access to newly-developed drugs which might cure them, according to a report released by the Korean-based Pharmaceutical Industry Association.

The report states that under the proposed plan, multinational pharmaceuticals will be restricted from bringing newly-invented drugs into Korea due to the complicated procedure...